Related references
Note: Only part of the references are listed.AQP1 Promoter Variant, Water Transport, and Outcomes in Peritoneal Dialysis
Johann Morelle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
ISPD recommendations for the evaluation of peritoneal membrane dysfunction in adults: Classification, measurement, interpretation and rationale for intervention
Johann Morelle et al.
PERITONEAL DIALYSIS INTERNATIONAL (2021)
Long-term outcomes in patients with encapsulating peritoneal sclerosis managed with nutritional support
Arunraj Navaratnarajah et al.
PERITONEAL DIALYSIS INTERNATIONAL (2020)
Treatments and outcomes of encapsulating peritoneal sclerosis in patients undergoing peritoneal dialysis: 295 cases from a nationwide inpatient database in Japan
Takaaki Konishi et al.
PERITONEAL DIALYSIS INTERNATIONAL (2020)
SURGICAL TREATMENT FOR ENCAPSULATING PERITONEAL SCLEROSIS: 24 YEARS' EXPERIENCE
Hideki Kawanishi et al.
PERITONEAL DIALYSIS INTERNATIONAL (2019)
Estimating risk of encapsulating peritoneal sclerosis accounting for the competing risk of death
Mark Lambie et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options
Rajesh M. Jagirdar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Encapsulating Peritoneal Sclerosis: The Abdominal Cocoon
Manphool Singhal et al.
RADIOGRAPHICS (2019)
Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients
Sudabeh Alatab et al.
RENAL FAILURE (2017)
LENGTH OF TIME ON PERITONEAL DIALYSIS AND ENCAPSULATING PERITONEAL SCLEROSIS - POSITION PAPER FOR ISPD: 2017 UPDATE
Edwina A. Brown et al.
PERITONEAL DIALYSIS INTERNATIONAL (2017)
Peritoneal inflammation precedes encapsulating peritoneal sclerosis: results from the GLOBAL Fluid Study
Mark R. Lambie et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
Georgios Liappas et al.
ONCOTARGET (2016)
Incidence and outcome of encapsulating peritoneal sclerosis
Michaela C. Petrie et al.
CLINICAL KIDNEY JOURNAL (2016)
Interstitial Fibrosis Restricts Osmotic Water Transport in Encapsulating Peritoneal Sclerosis
Johann Morelle et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
DESIGNING EPIDEMIOLOGY STUDIES TO DETERMINE THE INCIDENCE AND PREVALENCE OF ENCAPSULATING PERITONEAL SCLEROSIS (EPS)
Dorothea Nitsch et al.
PERITONEAL DIALYSIS INTERNATIONAL (2015)
CAN EPS DEVELOPMENT BE AVOIDED WITH EARLY INTERVENTIONS? THE POTENTIAL ROLE OF TAMOXIFEN-A SINGLE-CENTER STUDY
Erika De Sousa-Amorim et al.
PERITONEAL DIALYSIS INTERNATIONAL (2014)
ENCAPSULATING PERITONEAL SCLEROSIS IN THE ERA OF A MULTI-DISCIPLINARY APPROACH BASED ON BIOCOMPATIBLE SOLUTIONS: THE NEXT-PD STUDY
Masaaki Nakayama et al.
PERITONEAL DIALYSIS INTERNATIONAL (2014)
Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: the experience of the Italian Registry of Pediatric Chronic Dialysis
Enrico Vidal et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group
Rukshana Shroff et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
NUTRITION CHANGES IN CONSERVATIVELY TREATED PATIENTS WITH ENCAPSULATING PERITONEAL SCLEROSIS
Nevine El-Sherbini et al.
PERITONEAL DIALYSIS INTERNATIONAL (2013)
Effects of Biocompatible versus Standard Fluid on Peritoneal Dialysis Outcomes
David W. Johnson et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
PERITONEAL MORPHOLOGY AFTER LONG-TERM PERITONEAL DIALYSIS WITH BIOCOMPATIBLE FLUID: RECENT CLINICAL PRACTICE IN JAPAN
Nobuhiro Ayuzawa et al.
PERITONEAL DIALYSIS INTERNATIONAL (2012)
Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study
Mario R. Korte et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
RISK FACTORS ASSOCIATED WITH ENCAPSULATING PERITONEAL SCLEROSIS IN DUTCH EPS STUDY
Mario R. Korte et al.
PERITONEAL DIALYSIS INTERNATIONAL (2011)
The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made
Mark L. Lambie et al.
KIDNEY INTERNATIONAL (2010)
Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes
David W. Johnson et al.
KIDNEY INTERNATIONAL (2010)
Slouching towards Bethlehem: the beast of biocompatibility
Joanne M. Bargman
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
THE ROLE OF PERITONEAL LAVAGE AND THE PROGNOSTIC SIGNIFICANCE OF MESOTHELIAL CELL AREA IN PREVENTING ENCAPSULATING PERITONEAL SCLEROSIS
Tadashi Yamamoto et al.
PERITONEAL DIALYSIS INTERNATIONAL (2010)
Encapsulating peritoneal sclerosis: experience of a tertiary referral center
P. J. Phelan et al.
RENAL FAILURE (2010)
Encapsulating Peritoneal Sclerosis in the New Millennium: A National Cohort Study
Michaela C. Brown et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis
Gowrie Balasubramaniam et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Assessing the Validity of an Abdominal CT Scoring System in the Diagnosis of Encapsulating Peritoneal Sclerosis
Ruth M. Tarzi et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation
Mario R. Korte et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Clinical characteristics of dialysis related sclerosing encapsulating peritonitis: Multi-center experience in Korea
BS Kim et al.
YONSEI MEDICAL JOURNAL (2005)
Sclerosing encapsulating peritonitis as a complication of long-term continuous ambulatory peritoneal dialysis in Korea
HY Lee et al.
NEPHROLOGY (2003)
Expression of TGF-β and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity
A Khanna et al.
KIDNEY INTERNATIONAL (2002)
Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients
S Hoshii et al.
PEDIATRIC NEPHROLOGY (2000)
Share Paper
